DLA Piper advises Onviv on investment by Decera Clinical

DLA Piper advised healthcare knowledge and network platform Onviv, Inc. (Onviv) on its investment by Decera Clinical, a healthcare portfolio company of The Riverside Company.

Onviv’s specialized lines of business include real-world intelligence, scientific communications, training sophistication, and stakeholder engagement that support informed decisions and drive meaningful outcomes for clients and patients. The transaction expands Decera Clinical’s capabilities across healthcare insights, scientific engagement, and medical communications, combining complementary expertise, proprietary methodologies, and longstanding industry relationships.

The DLA Piper deal team was led by Partner Scott Cowan and Paul Nolle.

With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been ranked number one in global M&A volume for 16 consecutive years by Mergermarket.